Pharma Reviews: Big Pharma, squeezed by govt crackdown and mounting lawsuits, eyes India's burgeoning opioid ...

As major pharmaceutical companies look to capitalise on the opportunity, the playbook unfolding in India seems eerily familiar. American ...
Read more: Big Pharma, squeezed by govt crackdown and mounting lawsuits, eyes India's burgeoning opioid ...

Pharma Reviews: China Relaxes Import Regulations to Improve Access and Availability of Affordable Medicines

There are many complementarities that can be unleashed by the Indian Pharmaceutical industry which is today at a high level of maturity and widely ...
Read more: China Relaxes Import Regulations to Improve Access and Availability of Affordable Medicines

US FDA News: E-Cigarette Products: Safety Communication - Due to the Incidents of Severe Respiratory Disease Associated with Use of an E-Cigarette Product

Both the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention are working tirelessly to investigate the distressing incidents of severe respiratory disease associated with use of e-cigarette products.
Read more: E-Cigarette Products: Safety Communication - Due to the Incidents of Severe Respiratory Disease Associated with Use of an E-Cigarette Product

Pharma Reviews: China Relaxes Import Regulations to Improve Access and Availability of Affordable Medicines

Council for Pharma and Healthcare Lauds Move as Significant for Indian and Global Generics ... There are many complementarities that can be unleashed by the Indian Pharmaceutical industry which is today at a high level of ...
Read more: China Relaxes Import Regulations to Improve Access and Availability of Affordable Medicines

Pharma Reviews: Belgium's Ajinomoto Bio-Pharma buys Indian API plant

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, has ...
Read more: Belgium's Ajinomoto Bio-Pharma buys Indian API plant

US FDA News: Statement on federal and state collaboration to investigate respiratory illnesses reported after use of e-cigarette products

FDA and CDC are providing updates about federal and state efforts to investigate respiratory illnesses reported after the use of e-cigarette products.
Read more: Statement on federal and state collaboration to investigate respiratory illnesses reported after use of e-cigarette products

Pharma Reviews: 'Health Meets Hope' at OPPI Health Dialogue 2019

The Organisation of Pharmaceutical Producers of India (OPPI) recently organised Health Dialogue 2019 in Delhi with the mission 'Health Meets Hope' ...
Read more: 'Health Meets Hope' at OPPI Health Dialogue 2019

Pharma Reviews: Concerns grow in the US over contamination of drugs made in Indian pharma facilities

Earlier this month, American drug regulator FDA issued a warning letter to an India-based manufacturer named Lantech Pharmaceuticals over traces ...
Read more: Concerns grow in the US over contamination of drugs made in Indian pharma facilities

US FDA News: FDA recommends health care facilities and manufacturers begin transitioning to duodenoscopes with disposable components to reduce risk of patient infection

FDA recommends duodenoscope manufacturers and health care facilities transition to different types of duodenoscopes that may pose less risk to patient safety.
Read more: FDA recommends health care facilities and manufacturers begin transitioning to duodenoscopes with disposable components to reduce risk of patient infection

US FDA News: Hepatitis C Medicines (Mavyret, Zepatier, and Vosevi): Drug Safety Communication - Due to Rare Occurrence of Serious Liver Injury in Some patients with Advanced Liver Disease

FDA has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic Hepatitis C in patients with moderate to severe liver impairment has resulted in rare cases of worsening liver function or liver failure.
Read more: Hepatitis C Medicines (Mavyret, Zepatier, and Vosevi): Drug Safety Communication - Due to Rare Occurrence of Serious Liver Injury in Some patients with Advanced Liver Disease

US FDA News: Hepatitis C Medicines (Mavyret, Zepatier, and Vosevi): Drug Safety Communication - Due to Rare Occurrence of Serious Liver Injury in Some patients with Advanced Liver Disease

FDA has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic Hepatitis C in patients with moderate to severe liver impairment has resulted in rare cases of worsening liver function or liver failure.
Read more: Hepatitis C Medicines (Mavyret, Zepatier, and Vosevi): Drug Safety Communication - Due to Rare Occurrence of Serious Liver Injury in Some patients with Advanced Liver Disease

Pharma Reviews: India Leadership Conclave 2019 Debates "Opportunities - Can India Seize India USD 5 Trillion ...

(Eds: Disclaimer: The following press release comes to you under an arrangement with Business Wire India. PTI takes no editorial responsibility for the ...
Read more: India Leadership Conclave 2019 Debates "Opportunities - Can India Seize India USD 5 Trillion ...

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on federal preparedness and FDA’s response efforts to the Ebola virus outbreak in the Democratic Republic of Congo

FDA committed to helping the people of the Democratic Republic of Congo effectively confront and end the current Ebola virus outbreak
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on federal preparedness and FDA’s response efforts to the Ebola virus outbreak in the Democratic Republic of Congo

US FDA News: FDA seeks permanent injunction against company selling unapproved hand sanitizers that claim to prevent infections from numerous pathogens

FDA seeks permanent injunction against company selling unapproved hand sanitizers that claim to prevent infections from numerous pathogens
Read more: FDA seeks permanent injunction against company selling unapproved hand sanitizers that claim to prevent infections from numerous pathogens

US FDA News: FDA authorizes emergency use of first Ebola fingerstick test with portable reader

FDA authorizes emergency use of first Ebola fingerstick test with portable reader
Read more: FDA authorizes emergency use of first Ebola fingerstick test with portable reader

US FDA News: Statement on the agency’s ongoing efforts to resolve safety issue with ARB medications

The FDA is issuing an update regarding the ongoing efforts to resolve safety issues with ARB medications.
Read more: Statement on the agency’s ongoing efforts to resolve safety issue with ARB medications

Pharma Reviews: China's new drug law may open door for Indian generic medicines: Report

India has been demanding that China open its pharmaceutical market to Indian drugs as part of the efforts to lower the USD 57 billion trade deficit in ...
Read more: China's new drug law may open door for Indian generic medicines: Report

Pharma Reviews: Explainer: How Indian pharma companies are riding the biosimilars wave

Indian pharmaceutical companies have been betting big on biosimilars for quite a while as they hope to cash in on its potentially large market.
Read more: Explainer: How Indian pharma companies are riding the biosimilars wave

US FDA News: FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease

FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease
Read more: FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen agency’s safety requirements aimed at mitigating risks associated with transmucosal immediate-release fentanyl products

FDA is taking new steps to strengthen agency’s safety requirements aimed at mitigating risks associated with transmucosal immediate-release fentanyl products
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen agency’s safety requirements aimed at mitigating risks associated with transmucosal immediate-release fentanyl products

US FDA News: FDA requests recall of sterile compounded drug products produced by Pacifico National Inc., dba AmEx Pharmacy, reminds patients and health care professionals to stop using due to potential risks

The FDA is requesting a recall of sterile compounded drug products produced by Pacifico National Inc., dba AmEx Pharmacy.
Read more: FDA requests recall of sterile compounded drug products produced by Pacifico National Inc., dba AmEx Pharmacy, reminds patients and health care professionals to stop using due to potential risks

US FDA News: Statement calling on all sectors of the papaya industry to improve practices to better protect consumers

FDA issues letter to all sectors of papaya industry to improve their safety practices
Read more: Statement calling on all sectors of the papaya industry to improve practices to better protect consumers

Pharma Reviews: Chennai startup Eywa enters US pharma market

MUMBAI: As India's largest drugmakers stare at an uncertain future in the US, a small startup funded by Chennai-based Shriram Group and Eight ...
Read more: Chennai startup Eywa enters US pharma market

Pharma Reviews: The dangerous cocktail of substandard drugs and poor regulatory oversight in India

Last week, the Health Ministry suspended an official of India's drug regulatory ... Indian should move towards adopting Pharmaceutical Inspection ...
Read more: The dangerous cocktail of substandard drugs and poor regulatory oversight in India

Pharma Reviews: Bitter battle

Predictably, the narrative of lack of regulation and poor quality has left the Indian pharma industry frothing at the mouth. According to the Indian Drug ...
Read more: Bitter battle

US FDA News: FDA confirms elevated levels of belladonna in certain homeopathic teething products

The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label. The agency is warning consumers that homeopathic teething tablets containing belladonna pose an unnecessary risk to infants and children and urges consumers not to use these products.
Read more: FDA confirms elevated levels of belladonna in certain homeopathic teething products

US FDA News: FDA proposes new, risk-based enforcement priorities to protect consumers from potentially harmful, unproven homeopathic drugs

Today, the U.S. Food and Drug Administration proposed a new, risk-based enforcement approach to drug products labeled as homeopathic. To protect consumers who choose to use homeopathic products, this proposed new approach would update the FDA’s existing policy to better address situations where homeopathic treatments are being marketed for serious diseases and/or conditions but where the products have not been shown to offer clinical benefits. It also covers situations where products labeled as homeopathic contain potentially harmful ingredients or do not meet current good manufacturing practices.
Read more: FDA proposes new, risk-based enforcement priorities to protect consumers from potentially harmful, unproven homeopathic drugs

Pharma Reviews: Why Indian pharma needs more expats on boards

ET Intelligence Group: While Indian pharmaceutical companies have been manufacturing and marketing drugs across continents for the past several ...
Read more: Why Indian pharma needs more expats on boards

Pharma Reviews: Indian scientist appointed global head of Public Heath Discovery at Johnson and Johnson

With more than 18 years of experience in pharmaceutical drug research, Dr Koul was one of the key scientists involved in discovery of Bedaquiline - a ...
Read more: Indian scientist appointed global head of Public Heath Discovery at Johnson and Johnson

Pharma Reviews: Lupin to sell Japanese injectable biz to Neopharma group

Indian Pharma major Lupin Limited (including its subsidiaries together ... its Japanese subsidiary Kyowa (Kyowa Pharmaceutical Industry Co., Ltd.) for ...
Read more: Lupin to sell Japanese injectable biz to Neopharma group

Pharma Reviews: Health Meets Hope at OPPI Health Dialogue 2019

The Health Dialogue 2019, curated by the Organisation of Pharmaceutical Producers of India (OPPI), witnessed policy makers, regulators, global ...
Read more: Health Meets Hope at OPPI Health Dialogue 2019

Pharma Reviews: Disruption to hit Indian drug cos' sales, margins

MUMBAI – Indian pharmaceutical companies can't seem to catch a break. Just as these drugmakers were beginning to crawl out of the woods in the ...
Read more: Disruption to hit Indian drug cos' sales, margins

Pharma Reviews: Indian pharma firms receive 34% of FDA warnings this year

Indian pharmaceutical companies received a third of the warnings the United States Food and Drug Administration (FDA) issued for misbranding, ...
Read more: Indian pharma firms receive 34% of FDA warnings this year

Pharma Reviews: These 12 Nifty stocks trading at discount to 5-yr avg P/E; time to buy?

Benchmark indices, even after the recent correction, are trading at a slight premium to historical averages but there are many individual stocks that are ...
Read more: These 12 Nifty stocks trading at discount to 5-yr avg P/E; time to buy?

Pharma Reviews: Indian medical representatives are giving quacks cash and gifts to sell antibiotics

Two of India's biggest drug companies are alleged to be giving inducements to quack doctors of gifts and cash to encourage them to prescribe vast ...
Read more: Indian medical representatives are giving quacks cash and gifts to sell antibiotics

Pharma Reviews: Sunil Singhania on how market recovery may precede economic recovery

The genesis of that was the market cap of the whole pharma sector in India was less than that of DLF in 2008. It was a screaming buy with prices very ...
Read more: Sunil Singhania on how market recovery may precede economic recovery

Pharma Reviews: India, Kenya explore ways to expand trade ties

New Delhi, Aug 20 () India and Kenya on Tuesday discussed ways to further ... The Indian delegation was led by Commerce and Industry Minister Piyush ... sought investments in their special economic zones and the pharma sector.
Read more: India, Kenya explore ways to expand trade ties

Pharma Reviews: India and Kenya review developments in bilateral trade at Joint Trade Committee

Indian side informed that Indian export of pharmaceutical products to Africa constitutes about 20% of India's total Pharma exports, and this has grown ...
Read more: India and Kenya review developments in bilateral trade at Joint Trade Committee

US FDA News: FDA warns company for putting consumers at risk with drug manufacturing data integrity violations

The FDA posted a warning letter for significant current good manufacturing practice violations, including data integrity issues.
Read more: FDA warns company for putting consumers at risk with drug manufacturing data integrity violations

US FDA News: Statement on new results demonstrating continued success of the agency’s youth smoking prevention efforts and significant public health cost savings

A new study in the American Journal of Preventive Medicine highlights the continued success and impact the FDA’s “The Real Cost” campaign has had on youth smoking initiation.
Read more: Statement on new results demonstrating continued success of the agency’s youth smoking prevention efforts and significant public health cost savings

Pharma Reviews: China is shopping for generics. Can Sun, Cipla, Alembic, and Aurobindo cash in?

Beijing has announced a raft of reforms for procuring generic drugs. This has renewed hope for Indian pharma companies, which in the last two ...
Read more: China is shopping for generics. Can Sun, Cipla, Alembic, and Aurobindo cash in?

Pharma Reviews: Buy these 15 handpicked stocks for 11-44% return in next one year

The same trend is likely to be followed in India too," he added. .... The industry, in general, has bottomed led by Sun Pharma which is currently trading ...
Read more: Buy these 15 handpicked stocks for 11-44% return in next one year

US FDA News: FDA approves new antibiotic to treat community-acquired bacterial pneumonia

The FDA approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.
Read more: FDA approves new antibiotic to treat community-acquired bacterial pneumonia

US FDA News: FDA warns consumers about the dangerous and potentially life threatening side effects of Miracle Mineral Solution

The FDA is warning consumers not to purchase or drink Miracle Mineral Solution, a product sold online as a medical treatment due to a recent rise in reported health issues.
Read more: FDA warns consumers about the dangerous and potentially life threatening side effects of Miracle Mineral Solution

Pharma Reviews: Accutest Biologics receives global honour

India's clinical contract research industry, with current market size of USD ... Rising demand for low cost medicines, growth of R&D sourcing, a large ...
Read more: Accutest Biologics receives global honour

Pharma Reviews: Sensex surges 300 points, Sun Pharma leads gains in pharma stocks: 10 updates

Indian stock markets moved broadly higher today, tracking gains in other ... 1) Sun Pharmaceutical Industries rose 4% after the company signed a ...
Read more: Sensex surges 300 points, Sun Pharma leads gains in pharma stocks: 10 updates

Pharma Reviews: Indian shares gain in line with broader Asia; pharma sector shines

"There is some buying in the pharmaceutical basket because of a lack of opportunity in the overall arena," said Saurabh Jain, assistant vice-president ...
Read more: Indian shares gain in line with broader Asia; pharma sector shines

Pharma Reviews: CBI arrests Deputy Drug Controller over graft charge

Sharma was also elected as the President of the Delhi chapter of the Indian Pharmaceutical Associatione (IPA) in 2018. IPA is an association of ...
Read more: CBI arrests Deputy Drug Controller over graft charge

Pharma Reviews: Market Live: Nifty above 11100, Sensex up 300 pts; Spandana Sphoorty debuts at discount

Indian indices are trading near the day's high level with Nifty above 11,100. ... Bharti Infratel, Sun Pharma, Dr Reddy's Laboratories, L&T and NTPC are the ... Buzzing: Shares of Sun Pharmaceutical Industries rallied 4.7 percent on ...
Read more: Market Live: Nifty above 11100, Sensex up 300 pts; Spandana Sphoorty debuts at discount

Pharma Reviews: CBI arrests Deputy Drug Controller over graft charges

Sharma was also elected as the President of the Delhi chapter of the Indian Pharmaceutical Alliance (IPA) in 2018. IPA is the lobby group of top Indian ...
Read more: CBI arrests Deputy Drug Controller over graft charges

Pharma Reviews: India business news headlines weekly roundup 12th to 16th July

Murali K Divi, CMD, Divi's Laboratories is said to be the highest-paid executive of the Indian pharma industry with a remuneration of Rs.58.8 crores ...
Read more: India business news headlines weekly roundup 12th to 16th July

US FDA News: FDA approves new device to improve symptoms in patients with advanced heart failure

FDA approves new device to improve symptoms in patients with advanced heart failure
Read more: FDA approves new device to improve symptoms in patients with advanced heart failure

Pharma Reviews: IICT keen to develop more

... products of Indian origin as it works on developing new molecules that can be used by the pharma industry to develop medicines. Of specific interest ...
Read more: IICT keen to develop more

Pharma Reviews: BQuick On Aug. 16: Top 10 Stories In Under 10 Minutes

The ministry noted Indian promoters have had to cede control of companies .... This is the first time ever, in the domestic pharma industry, that as the ...
Read more: BQuick On Aug. 16: Top 10 Stories In Under 10 Minutes

US FDA News: FDA expands indication for several transcatheter heart valves to patients at low risk for death or major complications associated with open-heart surgery

FDA expands indication for several transcatheter heart valves to patients at low risk for death or major complications associated with open-heart surgery.
Read more: FDA expands indication for several transcatheter heart valves to patients at low risk for death or major complications associated with open-heart surgery

US FDA News: FDA approves first of its kind device to treat pediatric patients with progressive idiopathic scoliosis

FDA approves first of its kind device to treat pediatric patients with progressive idiopathic scoliosis
Read more: FDA approves first of its kind device to treat pediatric patients with progressive idiopathic scoliosis

US FDA News: FDA approves treatment for patients with rare bone marrow disorder

FDA approves treatment for adult patients with certain types of myelofibrosis.
Read more: FDA approves treatment for patients with rare bone marrow disorder

Pharma Reviews: Real Economy Check: 'Jammed Liquidity' To 'Overwhelming Regulations' Hurting Small ...

Second-generation entrepreneur Amit Sheth followed his father into India's pharmaceutical industry, nurturing a near 40-year-old business to a point ...
Read more: Real Economy Check: 'Jammed Liquidity' To 'Overwhelming Regulations' Hurting Small ...

Pharma Reviews: What's going on in the equity markets?

The pharma industry has a separate set of problems arising from its ... in the fate of Indian equity markets, only the state of the Indian economy and the ...
Read more: What's going on in the equity markets?

Pharma Reviews: GST Council to discuss rate cut on vehicles

The meeting in September will also look into input tax credit for pharma sector, GST hike on premium realty projects.
Read more: GST Council to discuss rate cut on vehicles

US FDA News: FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor

FDA approves third cancer treatment based on a common biomarker across different types of tumors rather than the location in the body where the tumor originated
Read more: FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor

Pharma Reviews: Lonza India aims at 15% annual growth

Describing India as a strategic market, Lonza India Managing Director ... The company has been catering to pharma sector giants likes Cipla, Sun, ...
Read more: Lonza India aims at 15% annual growth

US FDA News: FDA proposes new required health warnings with color images for cigarette packages and advertisements to promote greater public understanding of negative health consequences of smoking

FDA has issued a proposed rule to require new health warnings on cigarette packages and in ads to promote greater public understanding of the negative health consequences of smoking.
Read more: FDA proposes new required health warnings with color images for cigarette packages and advertisements to promote greater public understanding of negative health consequences of smoking

Pharma Reviews: Indian pharma industry may achieve double-digit growth by 2030 via regulatory support from ...

Ahmedabad: Indian pharmaceutical industry can achieve a target of double-digit growth by 2030 through a host of measures including regulatory ...
Read more: Indian pharma industry may achieve double-digit growth by 2030 via regulatory support from ...

Pharma Reviews: Pick these 5 stocks for 22-38% returns by next Independence Day

The Global pharmaceutical industry is at crossroads with increasing ... portfolio and positioning themselves as the 'World's favourite Indian' brand.
Read more: Pick these 5 stocks for 22-38% returns by next Independence Day

Pharma Reviews: Pharma wants a booster fund to push innovation

AHMEDABAD | MUMBAI: The Indian Pharmaceutical Alliance, a group of top research-based pharmaceutical companies, has urged policy think tank ...
Read more: Pharma wants a booster fund to push innovation

Pharma Reviews: Sun, CSIR-IICT Ink Global Licensing Pact for Patents

MUMBAI: In one of the rare partnerships between the industry and academic institutions, Sun Pharma, India's largest drug maker, said that it has ...
Read more: Sun, CSIR-IICT Ink Global Licensing Pact for Patents

Pharma Reviews: Pharma wants a booster fund to push innovation

The Indian Pharmaceutical Alliance, a group of top research-based pharmaceutical companies, has urged policy think tank Niti Aayog and the ...
Read more: Pharma wants a booster fund to push innovation

Pharma Reviews: Sun pharma, CSIR arm in Rs 240 crore licensing pact

Sun Pharmaceutical Industries has entered into a global licensing agreement with the CSIR Indian Institute of Chemical Technology, Hyderabad ...
Read more: Sun pharma, CSIR arm in Rs 240 crore licensing pact

Pharma Reviews: Opinion | A complex challenge for our private sector

It does boast of a few cement and yarn units, and a few consumer-product companies like Dabur India, pharma firms such as Cadila Pharmaceuticals ...
Read more: Opinion | A complex challenge for our private sector

Pharma Reviews: Pharma body IPA not in favour of extending trade margin cap to all drugs

Indian Pharmaceutical Alliance (IPA), the lobby group representing large domestic drug makers, has said it is not in favour of government extending ...
Read more: Pharma body IPA not in favour of extending trade margin cap to all drugs

Pharma Reviews: Indian Pharmaceutical Industry May Achieve Double-Digit Growth By 2030

The Indian pharmaceutical industry can achieve a target of double-digit growth by 2030 through a host of measures including regulatory support from ...
Read more: Indian Pharmaceutical Industry May Achieve Double-Digit Growth By 2030

US FDA News: FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs

FDA approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.
Read more: FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs

Pharma Reviews: Sun Pharma to make upfront payment worth Rs 2.40 bn to CSIR-IICT Hyderabad for new drug ...

Sun Pharma to make upfront payment worth Rs 2.40 bn to CSIR-IICT ... to bring innovations from Indian research institutes to the market to address the ...
Read more: Sun Pharma to make upfront payment worth Rs 2.40 bn to CSIR-IICT Hyderabad for new drug ...

Pharma Reviews: Sun Pharma inks global licensing pact with CSIR-IICT for patents

Sun Pharmaceutical Industries on Wednesday said it has entered into a global licensing pact with Hyderabad-based CSIR Indian Institute of Chemical ...
Read more: Sun Pharma inks global licensing pact with CSIR-IICT for patents

Pharma Reviews: To fix quality of Indian drugs, Modi govt plans to tighten transportation & storage laws

New Delhi: The Modi government is set to further regulate the under-fire pharmaceutical sector, this time targeting the storage and distribution ...
Read more: To fix quality of Indian drugs, Modi govt plans to tighten transportation & storage laws

Pharma Reviews: CNBC-TV18 Market Live Opening Bell: Nifty starts below 11000, Sensex surges over 180 points ...

CNBC-TV18 Market Live Opening Bell: Indian shares opened higher on ... Dr Reddy's Labs, Yes Bank, Sun Pharma, Power Grid and Indian Oil Corp ...
Read more: CNBC-TV18 Market Live Opening Bell: Nifty starts below 11000, Sensex surges over 180 points ...

Pharma Reviews: Sun Pharmaceutical Industries Q1 profit at Rs 1387 crore

New Delhi: Sun Pharmaceutical Industries on Tuesday reported a ... 8.2 per cent market share in the over Rs 1,32,000 crore Indian pharmaceutical ...
Read more: Sun Pharmaceutical Industries Q1 profit at Rs 1387 crore

Pharma Reviews: JSW Energy gets shareholders' nod to raise USD 750 mn via bonds

Indian pharmaceutical industry can achieve a target of double-digit growth by 2030 through a host of measures including regulatory support from ...
Read more: JSW Energy gets shareholders' nod to raise USD 750 mn via bonds

Pharma Reviews: Indian pharma industry may achieve double-digit growth by 2030

As per a report prepared by the IPA, at its current rate of 7-8 per cent CAGR, the Indian pharmaceutical industry is expected to grow about USD 80 to ...
Read more: Indian pharma industry may achieve double-digit growth by 2030

Pharma Reviews: Sun Pharma Q1 profit jumps 31% to Rs 1387 crore, sales rises 16%

"The Mumbai-headquartered pharma firm had reported a net profit of Rs ... India sales, which accounted for 28 per cent of total sales, climbed 8 per ...
Read more: Sun Pharma Q1 profit jumps 31% to Rs 1387 crore, sales rises 16%

Pharma Reviews: Sun Pharma Q1 profit at Rs 1387 cr

"Sun Pharma is ranked number 1 and holds approximately 8.2 per cent market share in the over Rs 1,32,000 crore Indian pharmaceutical market as ...
Read more: Sun Pharma Q1 profit at Rs 1387 cr

US FDA News: FDA warns consumers about the dangerous and potentially life threating side effects of Miracle Mineral Solution

The FDA is warning consumers not to purchase or drink Miracle Mineral Solution, a product sold online as a medical treatment due to a recent rise in reported health issues.
Read more: FDA warns consumers about the dangerous and potentially life threating side effects of Miracle Mineral Solution

Pharma Reviews: Pages and pieces of freedom of an artefacts collector's pride

After graduating from Calcutta University, Ray joined the pharma industry. “I started buying books on our freedom movement and built a mini library at ...
Read more: Pages and pieces of freedom of an artefacts collector's pride

Pharma Reviews: Divis Labs Chairman C Murali K Divi highest paid Indian pharma executive, Check out his ...

New Delhi; Chairman and Managing Director of city-based pharma company C Murali K Divi is the highest paid executive of the Indian pharma ...
Read more: Divis Labs Chairman C Murali K Divi highest paid Indian pharma executive, Check out his ...

Pharma Reviews: Murali of Divi's Lab highest paid Indian pharma honcho in FY19

Hyderabad: Chairman and Managing Director of city-based pharma company Divi's Laboratories Murali K Divi is the highest paid executive of the ...
Read more: Murali of Divi's Lab highest paid Indian pharma honcho in FY19

Pharma Reviews: At Rs 58.8 cr, Murali of Divi's Lab highest paid Indian pharma executive

Chairman and Managing Director of city-based pharma company C Murali K Divi is the highest paid executive of the Indian pharma industry with Rs ...
Read more: At Rs 58.8 cr, Murali of Divi's Lab highest paid Indian pharma executive

Pharma Reviews: Murali of Divi's Lab highest-paid chief of Indian pharma with Rs 58.8 crore

Chairman and Managing Director of city-based pharma company Divi's Laboratories Murali K Divi is the highest paid executive of the Indian pharma ...
Read more: Murali of Divi's Lab highest-paid chief of Indian pharma with Rs 58.8 crore

Pharma Reviews: China's pharmaceutical market reforms could benefit Indian drug-makers: Jefferies India

Though the Chinese market resembled India's, with high branded generics share, and low regulatory requirements, following reforms, China could ...
Read more: China's pharmaceutical market reforms could benefit Indian drug-makers: Jefferies India

US FDA News: FDA sends warning to company for marketing dangerous unapproved stem cell products that put patients at risk and puts other stem cell firms, providers on notice

FDA sends warning letter to Genetech, Inc. and letters to other companies to reiterate the FDA’s compliance and enforcement policy regarding stem cells.
Read more: FDA sends warning to company for marketing dangerous unapproved stem cell products that put patients at risk and puts other stem cell firms, providers on notice

Pharma Reviews: Divi's Lab's Murali Divi was the highest earning pharma promoter-executive in FY19

Murali Divi, the low profile CMD of Divis Labs, has once again emerged as the highest paid executive of the Indian pharmaceutical industry in FY19.
Read more: Divi's Lab's Murali Divi was the highest earning pharma promoter-executive in FY19

Pharma Reviews: Can Jammu & Kashmir build on its pharma base?

Jammu & Kashmir may not be a big market for the Indian pharmaceutical industry, it has a lot to offer to the sector. Industry estimates pharma market ...
Read more: Can Jammu & Kashmir build on its pharma base?

US FDA News: FDA notifies four companies to remove 44 flavored e-liquid and hookah tobacco products from the market for not having required marketing authorization

FDA has notified four firms that 44 flavored e-liquid and hookah tobacco products do not have the required marketing authorization, and thus cannot be legally sold in the U.S.
Read more: FDA notifies four companies to remove 44 flavored e-liquid and hookah tobacco products from the market for not having required marketing authorization

Pharma Reviews: India: Government Role In Indian Pharmaceutical Industry To Achieve Vision 2030

The report lists the growth ambitions that Indian pharmaceutical industry ('Industry') needs to follow to achieve its targets for year 2030 (Vision 2030).
Read more: India: Government Role In Indian Pharmaceutical Industry To Achieve Vision 2030

Pharma Reviews: Aurobindo eyes rapid growth in US market

Notwithstanding the regulatory challenges, Aurobindo Pharma Ltd is betting big on the US market, which accounts for nearly half of the firm's revenue.
Read more: Aurobindo eyes rapid growth in US market

Pharma Reviews: Indian Pharma- Reputation Gap

The Indian pharmaceutical industry follows stringent quality standards set by global regulatory agencies. The generic drugs that we manufacture ...
Read more: Indian Pharma- Reputation Gap

Pharma Reviews: Lupin's Aurangabad plant passes USFDA inspection

It is also the 3rd largest Indian pharmaceutical company by global revenues and the 5th largest company in the Indian Pharmaceutical Market.
Read more: Lupin's Aurangabad plant passes USFDA inspection

Pharma Reviews: India to rethink RCEP engagement if China denies market access

Even without the deal, India's merchandise trade deficit with the RCEP ... in key sectors — including IT, pharma and agriculture — to its endorsement of an ... This, Indian industry feels, is among the main reasons as to why China has ...
Read more: India to rethink RCEP engagement if China denies market access

Pharma Reviews: Legacy of scientific temper

Large multinational pharmaceutical companies held monopolies over the ... By 1997, however, the vaccine in India was available for just Rs. 100 ...
Read more: Legacy of scientific temper

Pharma Reviews: Sector scan: Sun Pharma set to shut down part of Vadodara R&D unit, 80 staff may lose jobs

In a move that may leave around 80 employees jobless, Indian drug maker Sun Pharmaceutical has decided to shut down two of its clinical ...
Read more: Sector scan: Sun Pharma set to shut down part of Vadodara R&D unit, 80 staff may lose jobs

Pharma Reviews: IP fest focusses on pharma, start-ups

Ahmedabad: The third edition of Intellectual Property (IP) Fest 2019, jointly organized by Federation of Indian Chambers of Commerce and Industry ...
Read more: IP fest focusses on pharma, start-ups

Pharma Reviews: Indian's big pharma companies finding new growth opportunities in China

The presence of Indian pharmaceutical companies in the Chinese market has historically been negligible as the complexity of the country's medical ...
Read more: Indian's big pharma companies finding new growth opportunities in China